CA49937-1A - 0x000000000000699C

Males & Females of Non-Childbearing Potential

Morning

* Stipend may pay up to reflected amount.
Start Date: 
January 19, 2026 - 3:15pm
End Date: 
March 31, 2026 - 10:45am

Study Details

Study Number: CA49937
Group Number: 1A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $7,000.00

Study Criteria

Age: 19 - 55
BMI: 0 - 0
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat inflammatory bowel disease.
Route of Administration: Injection IV infusion; Injection subcutaneous
Blood Draws: 16

Study Schedule

Schedule Type: Short stays with returns
Study Length: 5 Night Stay & 5 Returns

Screening Dates:

Event Day Event Date
Monday 1/12/2026
Tuesday 1/13/2026
Friday 1/16/2026
Saturday 1/17/2026

Doctor Exam Dates:

Event Day Event Date
Monday 1/12/2026
Tuesday 1/13/2026
Friday 1/16/2026
Saturday 1/17/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Monday 1/19/2026 3:15:00 PM Saturday 1/24/2026 9:45:00 AM 1 Lincoln
Return Thursday 1/29/2026 8:35:00 AM Thursday 1/29/2026 9:45:00 AM 1 Lincoln
Return Tuesday 2/3/2026 8:35:00 AM Tuesday 2/3/2026 9:45:00 AM 1 Lincoln
Return Tuesday 2/17/2026 8:35:00 AM Tuesday 2/17/2026 9:45:00 AM 1 Lincoln
Return Tuesday 3/3/2026 8:35:00 AM Tuesday 3/3/2026 9:45:00 AM 1 Lincoln
Return Tuesday 3/31/2026 9:35:00 AM Tuesday 3/31/2026 10:45:00 AM 1 Lincoln